Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002012383-25-002433
Filing Date
2025-10-17
Accepted
2025-10-17 17:45:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5775
2 PowerOfAttorney.txt EX-24 2753
3 Item_7.txt EX-99 690
  Complete submission text file 0002012383-25-002433.txt   11171
Mailing Address 9490 NEOGENOMICS WAY FORT MYERS FL 33912
Business Address 9490 NEOGENOMICS WAY FORT MYERS FL 33912 2397680600
NEOGENOMICS INC (Subject) CIK: 0001077183 (see all company filings)

EIN.: 742897368 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-82969 | Film No.: 251401704
SIC: 8734 Services-Testing Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5800
BlackRock, Inc. (Filed by) CIK: 0002012383 (see all company filings)

EIN.: 991116001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)